-
公开(公告)号：EP3287522A1
公开(公告)日：2018-02-28
申请号：EP16783128.8
申请日：2016-04-19
IPC分类号： C12N15/09 , A61K39/395 , A61P35/00 , C07K16/28 , C12N1/15 , C12N1/19 , C12N1/21 , C12N5/10 , C12P21/08 , G01N33/48 , G01N33/53 , G01N33/577
CPC分类号： A61K39/39558 , A61P35/00 , C07K16/2863 , C07K2317/24 , C07K2317/33 , C07K2317/51 , C07K2317/565 , C07K2317/76 , C12N5/10 , C12N15/09 , G01N33/577 , G01N33/6893 , G01N2333/503
摘要： The present invention provides a pharmaceutical composition or a diagnostic composition targeting human fibroblast growth factor receptor 2 (hFGFR2).
摘要翻译： 本发明提供了靶向人成纤维细胞生长因子受体2（hFGFR2）的药物组合物或诊断组合物。
-
公开(公告)号：EP2837685B1
公开(公告)日：2020-09-09
申请号：EP13776053.4
申请日：2013-04-09
-
公开(公告)号：EP3561057A1
公开(公告)日：2019-10-30
申请号：EP17884717.4
申请日：2017-12-21
发明人： TAKAHASHI, Tohru , YOSHIMURA, Chigusa , KOZUMA, Shiho , NAKAMURA, Kensuke , SUZUKI, Chikako , ICHIKAWA, Junya
摘要： The present invention provides a novel antibody binding to human CD3, and a molecule having antigen binding activity that includes the antibody.
The present invention provides a novel antibody binding to human CD3, a molecule having antigen binding activity that includes the antibody, and a pharmaceutical composition having cytotoxic activity that includes the antibody or the molecule as an active ingredient.-
公开(公告)号：EP2837685A1
公开(公告)日：2015-02-18
申请号：EP13776053.4
申请日：2013-04-09
发明人： OHTSUKA, Toshiaki , YOSHIMURA, Chigusa , AGATSUMA, Toshinori , URANO, Atsushi , KIMURA, Takako , MATSUI, Yumi , MATSUOKA, Tatsuji , HASEGAWA, Jun , KAMAI, Yasuki , KAWAIDA, Reimi
IPC分类号： C12N15/09 , A61K39/395 , A61P35/00 , C07K16/28 , C12N1/15 , C12N1/19 , C12N1/21 , C12N5/10 , C12P21/08 , G01N33/574
摘要： The present invention provides an antibody which binds to a fibroblast growth factor receptor.
摘要翻译： 本发明提供了结合成纤维细胞生长因子受体的抗体。
-
-
-
搜索结果
4 条记录 (耗时 0.025 秒)
